These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15993950)

  • 21. Specific antitumor effects of tumor vaccine produced by electrofusion between osteosarcoma cell and dendritic cell in rats.
    Yu Z; Fan Q; Hao X; Long H
    Cell Mol Immunol; 2004 Dec; 1(6):454-60. PubMed ID: 16293215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte/macrophage colony-stimulating factor and interleukin-4-induced dendritic cells.
    Hikino H; Kasono K; Kanzaki M; Kai T; Konishi F; Kawakami M
    Anticancer Res; 2004; 24(3a):1609-15. PubMed ID: 15274330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice.
    Tian F; Wang L; Qin W; Wang F; Song B; Li Y; Wen W; Zhang Z; Zhu K; Zhang Q; Lee C; Zhong W; Guo Y; Wang H
    Cancer Lett; 2008 Nov; 271(2):333-41. PubMed ID: 18675506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy.
    Heckelsmiller K; Beck S; Rall K; Sipos B; Schlamp A; Tuma E; Rothenfusser S; Endres S; Hartmann G
    Eur J Immunol; 2002 Nov; 32(11):3235-45. PubMed ID: 12555669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-tumor effects induced by fusion of interleukin-18 gene transfected NCI-H460 lung cancer cell line with dendritic cells].
    Zhang ZY; Wu JM
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):17-20. PubMed ID: 17575687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
    Ovali E; Dikmen T; Sonmez M; Yilmaz M; Unal A; Dalbasti T; Kuzeyli K; Erturk M; Omay SB
    J Exp Clin Cancer Res; 2007 Jun; 26(2):209-14. PubMed ID: 17725100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
    Oh ST; Kim CH; Park MY; Won EH; Sohn HJ; Cho HI; Kang WK; Hong YK; Kim TG
    Vaccine; 2006 Apr; 24(15):2860-8. PubMed ID: 16443309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antitumor immune responses induced by idiotype-pulsed dendritic cells with cell-penetrating peptide vaccination in vivo].
    Chang JH; Shi YX; Zhiang XS; Jiang WQ; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):804-7. PubMed ID: 18396634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.
    Pilon-Thomas S; Li W; Briggs JJ; Djeu J; Mulé JJ; Riker AI
    J Immunother; 2006; 29(4):381-7. PubMed ID: 16799333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine.
    Kao JY; Gong Y; Chen CM; Zheng QD; Chen JJ
    J Immunol; 2003 Apr; 170(7):3806-11. PubMed ID: 12646647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in mice.
    Li B; Li Q; Zhao QL; Wei XB; Zhang XH; Wu CQ; Zhong CP
    Scand J Immunol; 2007 Jan; 65(1):8-13. PubMed ID: 17212761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice.
    Khamisabadi M; Arab S; Motamedi M; Khansari N; Moazzeni SM; Gheflati Z; Hadjati J
    Iran J Immunol; 2008 Mar; 5(1):36-44. PubMed ID: 18319523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].
    Deng YJ; Xia JC; Zhou J; Wang QJ; Zhang PY; Zhang LJ; Rong TH
    Ai Zheng; 2007 Feb; 26(2):137-41. PubMed ID: 17298741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
    Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
    Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibitory effect of dendritic cells pulsed with MAGE-3 peptide on transplanted murine gastric cancer in mice].
    Lü B; Liu BY; Zhang Y; Chen XH; Zhu ZG; Yin HR; Lin YZ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2120-3. PubMed ID: 16313822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
    López MN; Pereda C; Segal G; Muñoz L; Aguilera R; González FE; Escobar A; Ginesta A; Reyes D; González R; Mendoza-Naranjo A; Larrondo M; Compán A; Ferrada C; Salazar-Onfray F
    J Clin Oncol; 2009 Feb; 27(6):945-52. PubMed ID: 19139436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines.
    Kobie JJ; Wu RS; Kurt RA; Lou S; Adelman MK; Whitesell LJ; Ramanathapuram LV; Arteaga CL; Akporiaye ET
    Cancer Res; 2003 Apr; 63(8):1860-4. PubMed ID: 12702574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reduction of immunosuppression and shift to Th1 response by tumor-DC (dendritic cells) fusion vaccine].
    Iinuma H; Okinaga K; Fukushima R; Inaba T; Iwasaki K; Arai T; Tamura J; Kumagai H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1640-2. PubMed ID: 15553669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.